Mon.Aug 19, 2024

article thumbnail

Opinion: Private equity: health care’s vampire

STAT

Private equity firms are sucking the resources out of America’s hospitals and nursing homes, and feeding on doctors to generate profits. These firms — which pool funds from wealthy investors and are exempt from many of the regulations and disclosure requirements that apply to other types of investments — have spent a half-trillion dollars since 2018 buying up medical resources.

article thumbnail

BMS’ KarXT nears schizophrenia approval, but AbbVie and others wait in the wings

PharmaVoice

With fewer side effects, the new wave of upcoming drugs could improve patient adherence, and the competition for a large projected market is getting fierce.

290
290
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study exposes the dangerous ‘hidden’ mental burden of cancer on patients’ spouses

STAT

The distress from receiving a cancer diagnosis is something that clinicians widely anticipate in patients, but suffering often doesn’t just afflict the patient. It can blanket an entire household, burdening spouses and other family members with stress and anxiety and the exhausting routine of treating a life-threatening disease. But while standards exist for assessing and managing distress in patients, it’s often “hidden” in family members, sometimes with devastating

363
363
article thumbnail

EM Match Advice 45: 2024 MyERAS Updates– What EM Applicants Need to Know

ALiEM - Pharm Pearls

Dr. Sara Krzyzaniak, EM Match Advice Podcast Host and Stanford University PD, discusses key changes in the 2024 MyERAS (Electronic Residency Application Service) application that all EM applicants should know about. Take a listen to this short 14-minute, high-yield episode before submitting your application. Podcast 45: Key 2024 MyERAS updates Highlights Hometown preferences are now limited to 3 (no longer 5).

152
152
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

STAT+: Peter Orszag wants the FTC and DOJ to stop challenging health care mergers

STAT

Peter Orszag was instrumental in crafting the Affordable Care Act. Now, he wants federal antitrust authorities to ease up on their sharp scrutiny of health care transactions that he acknowledges the law has encouraged — and that make a lot of money for his investment bank. Orszag’s comments, made last week on TV, reveal how policymakers can end up profiting from the laws they help create.

Hospitals 363

More Trending

article thumbnail

STAT+: AI drug firm Recursion moves from survival to industry domination

STAT

SALT LAKE CITY — On paper, Recursion Pharmaceuticals shouldn’t have worked. The company — or, at least, what existed at its founding in 2013 — hoped to pull data from images of healthy and diseased cells, and use that data to identify drugs gathering dust on pharmaceutical company shelves that could be repurposed as rare disease treatments.

article thumbnail

Nature publishes new research on genetic causes of colorectal cancer

Pharma Times

In the UK study, researchers analysed 2,023 bowel cancers from the 100,000 Genomes Project

136
136
article thumbnail

Opinion: Graphic mpox images to educate the public are deeply problematic

STAT

For the second time in three years, the WHO has declared an mpox outbreak a public health emergency of international concern. Since news of the epidemic, the media has circulated images of patients infected with mpox. Some of these photographs show mpox on patients’ arms, legs, and hands, but others are headshots that resemble mugshots of African people with mpox covering their faces.

352
352
article thumbnail

US govt taps Walgreens for decentralised trials

pharmaphorum

Walgreens has signed a $100m contract with the US government's BARDA agency for access to its decentralised clinical trials network

134
134
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Will the FTC challenge a deal that would give Novo Nordisk control of some Catalent plants?

STAT

As the Federal Trade Commission scrutinizes the pharmaceutical industry, there is growing debate about whether the regulator may next target a deal that some experts say could make it easier for Novo Nordisk to boost production of a key drug — at the expense of competitors. At issue is a complicated transaction sparked by sporadic shortages of one of the world’s hottest-selling medications — the weight loss treatment Wegovy.

295
295
article thumbnail

Pharmacy crises highlighted in 'honest' NHS review

The Pharmacist

Pharmacy bodies have highlighted funding, workforce and medicine supply concerns to an independent review intended to 'diagnose' the challenges facing the NHS. Health and social care secretary Wes Streeting has commissioned the Darzi review to deliver 'a raw and frank assessment of the state of the NHS' next month. 'This is the necessary first step […] The post Pharmacy crises highlighted in 'honest' NHS review appeared first on The Pharmacist.

131
131
article thumbnail

STAT+: Another suit filed against FDA over lab-developed test rule

STAT

A group representing molecular pathologists sued the Food and Drug Administration on Monday over its plan to regulate lab-developed tests.  It’s the second legal challenge to the rule, following the American Clinical Laboratory Association’s suit in May. The suit, filed in Texas by the Association for Molecular Pathology and University of Texas pathologist Michael Laposata, claims that the FDA overstepped its regulatory bounds when deciding to regulate lab-developed tests.

290
290
article thumbnail

Novo plans new plant as it races to meet drug demand

PharmaVoice

The new factory, which Novo is committing some $220 million to build, will supply raw materials for the company’s chronic disease medicines.

130
130
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Patient volumes have stormed back into hospitals

STAT

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday. A self-interested plea from Peter Orszag Peter Orszag, CEO of Lazard, went on CNBC last week and criticized how the Federal Trade Commission and Department of Justice were gumming up health care mergers.

Hospitals 265
article thumbnail

As Bristol Myers’ schizophrenia drug nears approval, AbbVie and others hope to provide competition

BioPharma Dive

A new wave of antipsychotics could improve patient adherence. The race to corner this large projected market is already getting tight.

114
114
article thumbnail

Eli Lilly acquires Morphic in IBD portfolio expansion

Pharmaceutical Technology

Eli Lilly has concluded the acquisition of Morphic Holding at $57 per share, bolstering its inflammatory bowel disease portfolio.

105
105
article thumbnail

Pfizer and BioNTech's COVID/flu vaccine hits a hurdle

pharmaphorum

Pfizer and BioNTech have a phase 3 mishap with their combined COVID-19 and influenza vaccine, handing Moderna an advantage

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Sound Pharmaceuticals plans to stick with WuXi amid BIOSECURE Act rumblings

Pharmaceutical Technology

Looking to potentially market their flagship drug SPI-1005, Sound CEO Jonathan Kil is keen to retain WuXi AppTec as a partner.

98
article thumbnail

EU starts review of Enhertu in HER2-ultralow breast cancer

pharmaphorum

EU starts review of Enhertu in HER2-ultralow breast cancer Phil.

88
article thumbnail

South African president calls on WHO for better mpox response

Pharmaceutical Technology

Cyril Ramaphosa, the president of South Africa, has asked the WHO to ensure African countries have equitable access to mpox vaccines.

article thumbnail

Researchers make breakthrough in fight against COVID-19

World Pharma News

A team led by Jose Onuchic at Rice University and Paul Whitford at Northeastern University, both researchers at the National Science Foundation Physics Frontiers Center at the Center for Theoretical Biological Physics (CTBP) at Rice, has made a discovery in the fight against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus responsible for COVID-19.

82
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Novo Financially Commits $220 Million Toward New Plant in Denmark

Pharmaceutical Commerce

The 86,000 square-foot Køge facility will be fully functional by 2027.

81
article thumbnail

Safeguarding patient data: Four steps to consider when assessing your IT infrastructure

pharmaphorum

Safeguarding patient data is crucial in the healthcare industry. This article outlines four steps to consider when assessing your IT infrastructure to protect against ransomware and ensure the security of patient data.

75
article thumbnail

Novo plans new plant as it races to meet drug demand

BioPharma Dive

The new factory, which Novo is committing some $220 million to build, will supply raw materials for the company’s chronic disease medicines.

60
article thumbnail

EMA validates Type II Variation application for ENHERTU for breast cancer treatment

Pharmaceutical Business Review

ENHERTU, a HER2 directed a DXd antibody drug conjugate (ADC), was discovered by Daiichi Sankyo and is being jointly developed and commercialised by Daiichi Sankyo with AstraZeneca. The EMA’s validation of the application signifies the commencement of a detailed scientific evaluation by its Committee for Medicinal Products for Human Use. The application for ENHERTU is supported by data from the DESTINY-Breast06 Phase III trial, which was highlighted at the 2024 American Society of Clinical

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.